{"organizations": [], "uuid": "0aaf5321a6c6dc9d479c0a7f1d53b80751f01f3a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-achaogen-announces-positive-top-li/brief-achaogen-announces-positive-top-line-results-from-first-clinical-trial-of-orally-administered-antibacterial-candidate-c-scape-idUSASB0BZFD", "country": "US", "domain_rank": 408, "title": "BRIEF-Achaogen Announces Positive Top-Line Results From First Clinical Trial Of Orally-Administered Antibacterial Candidate C-Scape", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-02T15:15:00.000+02:00", "replies_count": 0, "uuid": "0aaf5321a6c6dc9d479c0a7f1d53b80751f01f3a"}, "author": "", "url": "https://www.reuters.com/article/brief-achaogen-announces-positive-top-li/brief-achaogen-announces-positive-top-line-results-from-first-clinical-trial-of-orally-administered-antibacterial-candidate-c-scape-idUSASB0BZFD", "ord_in_thread": 0, "title": "BRIEF-Achaogen Announces Positive Top-Line Results From First Clinical Trial Of Orally-Administered Antibacterial Candidate C-Scape", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "achaogen inc", "sentiment": "none"}, {"name": "orally-administered antibacterial candidate c-scape reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 16 PM / in 6 minutes BRIEF-Achaogen Announces Positive Top-Line Results From First Clinical Trial Of Orally-Administered Antibacterial Candidate C-Scape Reuters Staff \nJan 2 (Reuters) - Achaogen Inc: \n* ACHAOGEN ANNOUNCES POSITIVE TOP-LINE RESULTS FROM FIRST CLINICAL TRIAL OF ORALLY-ADMINISTERED ANTIBACTERIAL CANDIDATE C-SCAPE \n* ACHAOGEN INC - C-SCAPE WAS WELL TOLERATED ACROSS ALL DOSES STUDIED IN PHASE 1 TRIAL \n* ACHAOGEN INC - CONTINUE TO PLAN FOR PHASE 3 IN 2018 Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-02T15:15:00.000+02:00", "crawled": "2018-01-02T15:28:08.009+02:00", "highlightTitle": ""}